European Pulmonary Fibrosis Federation

Tweet this page
<
2016
2017
2018
2019
2020
2021
2022
2023
>
Registration as it was on 14 Sep 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

250,000€

Financial year: Jul 2016 - May 2017

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    European Idiopathic Pulmonary Fibrosis & Related Disorders Federation   (EU-IPFF)

    EU Transparency Register

    098968923496-04 First registered on 20 Sep 2016

    Goals / Remit

    The Association serves the following social and scientific non-profit aims, of international utility:

    a) Supporting an immediate and sustainable improvement of the quality of life and survival time of IPF patients, and of patients suffering from other interstitial lung diseases, through directly influencing pharmacological and medical research and development, as well as the access to non-pharmacological assistance for patients.

    b) Defending the interests of IPF patients at European level with emphasis on:

    - access to treatment and services, including non-pharmacological treatment and medication
    - access to information on new and current trials
    - promotion of research into new treatment/medication
    - information exchange and collaboration between European and international IPF patient associations
    - supporting the establishment of patient associations in countries where no such associations exist

    To achieve these goals, the association will undertake the following activities:
    - exchanging information and collaborating with relevant European and international organisations and bodies
    - involving patients in research activities and studies to improve current treatment options for IPF patients
    - representation in relevant European and international organisations
    - organisation of symposia, workshops, educational and training events for different stakeholders
    - providing information, e.g. via a website
    - publishing materials such as leaflets, brochures, books, audio-visual materials, etc.

    Main EU files targeted

    Defending the interests of IPF patients at European level with emphasis on:
    - access to treatment and services, including non-pharmacological treatment and medication
    - access to information on new and current trials
    - promotion of research into new treatment/medication
    - information exchange and collaboration between European and international IPF patient associations
    - supporting the establishment of patient associations in countries where no such associations exist

    Address

    Head Office
    Jules de Cocklaan 95
    Gentbrugge B-9050
    BELGIUM
  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Mr Liam Galvin (Secretary)

    Person with legal responsibility

    Mr Liam Galvin (Secretary)

  • Categories

    Category

    III - Non-governmental organisations

    Subcategory

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    None declared

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jul 2016 - May 2017

    Lobbying costs for closed financial year

    250,000€

    Other financial info

    The financial year of the Association runs from June 1 to May 31. The first financial year provided an exception with the financial year running from 15 July 2016 to 31 May 2017.

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard